Mark Frattini
Chief Tech/Sci/R&D Officer bei CELLECTIS S.A.
Vermögen: 40 306 $ am 31.03.2024
Profil
Mark Frattini is currently the Chief Medical Officer at Cellectis SA. He previously worked as the Director-Research at The Trustees of Columbia University in The City of New York from 2013 to 2018.
Mark also held the position of Executive Medical Director at Celgene SAS and was a Member-Adult Leukemia Service at Memorial Sloan Kettering Cancer Center.
He obtained a doctorate degree from The University of Chicago.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CELLECTIS SA
0,02% | 14.02.2023 | 15 000 ( 0,02% ) | 40 306 $ | 31.03.2024 |
Aktive Positionen von Mark Frattini
| Unternehmen | Position | Beginn |
|---|---|---|
| CELLECTIS S.A. | Chief Tech/Sci/R&D Officer | 28.09.2022 |
Ehemalige bekannte Positionen von Mark Frattini
| Unternehmen | Position | Ende |
|---|---|---|
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - |
Celgene SAS
 Celgene SAS Pharmaceuticals: MajorHealth Technology Celgene SAS wholesales pharmaceutical products. Its products include Revlimid, vidaza, thalidomide, imnovid, Abraxane and Otezla. The company was founded in 1984 and is headquartered in Paris La Défense, France. | Corporate Officer/Principal | - |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Ausbildung von Mark Frattini
| The University of Chicago | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CELLECTIS S.A. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Health Services |
Celgene SAS
Celgene SAS Pharmaceuticals: MajorHealth Technology Celgene SAS wholesales pharmaceutical products. Its products include Revlimid, vidaza, thalidomide, imnovid, Abraxane and Otezla. The company was founded in 1984 and is headquartered in Paris La Défense, France. | Health Technology |
